Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases.
To contact Derek email him directly: derekb.lowe@gmail.com
Twitter: Dereklowe
Here's an interview that I did recently with Paul Howard of the Manhattan Institute on the results of that immunotherapy leukemia trial (and on some broader topics around the current state of drug discovery). Anyone who would like to pitch a blockbuster syndicated radio show with me on structure-activity relationships and preclinical drug development, have your people call my people.
1. Sara Nunez-Garcia, Ph.D. on October 5, 2011 5:54 AM writes...
Hi Derek,
Nice interview and amazing blog. Was wondering if you would give a talk on the state of our industry at my Business School (INSEAD) next year. An off-line e-mail is on its way.
2. milkshake on October 6, 2011 12:28 AM writes...
Derek, in connection with themes discussed in your podcast: you may want to read about Ralph Steinman, the guy who got awarded the Medicine Nobel this year (one week after his death). He suffered a terminal metastatic pancreatic cancer and apparently he had performed some kind of brave experimental immunotherapy on himself - one that significantly prolonged his survival, probably by several years.
1. Sara Nunez-Garcia, Ph.D. on October 5, 2011 5:54 AM writes...
Hi Derek,
Nice interview and amazing blog. Was wondering if you would give a talk on the state of our industry at my Business School (INSEAD) next year. An off-line e-mail is on its way.
sara
Permalink to Comment2. milkshake on October 6, 2011 12:28 AM writes...
Derek, in connection with themes discussed in your podcast: you may want to read about Ralph Steinman, the guy who got awarded the Medicine Nobel this year (one week after his death). He suffered a terminal metastatic pancreatic cancer and apparently he had performed some kind of brave experimental immunotherapy on himself - one that significantly prolonged his survival, probably by several years.
bbc.co.uk/news/magazine-15156342
Permalink to Comment